| __timestamp | Celldex Therapeutics, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 101881000 | 22622695 |
| Thursday, January 1, 2015 | 4011000 | 24863028 |
| Friday, January 1, 2016 | 102026000 | 21351001 |
| Sunday, January 1, 2017 | 96171000 | 53837297 |
| Monday, January 1, 2018 | 66449000 | 16080096 |
| Tuesday, January 1, 2019 | 42672000 | 18525736 |
| Wednesday, January 1, 2020 | 42534000 | 2024000 |
| Friday, January 1, 2021 | 3068000 | 2548000 |
| Saturday, January 1, 2022 | 1400000 | 61556000 |
| Sunday, January 1, 2023 | 3008000 | 188157000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding the cost of revenue is crucial for evaluating a company's financial health. This analysis focuses on Telix Pharmaceuticals Limited and Celldex Therapeutics, Inc., two prominent players in the industry. Over the past decade, Celldex has experienced a significant fluctuation in its cost of revenue, peaking in 2014 and 2016 with values over 100 million, before plummeting to just 1.4 million in 2022. In contrast, Telix Pharmaceuticals has shown a more consistent upward trend, culminating in a staggering 188 million in 2023, marking an impressive 740% increase from its 2014 figures. This divergence highlights the varying strategies and market conditions faced by these companies. Investors and industry analysts should consider these trends when assessing the potential risks and opportunities within the biotech sector.
Cost of Revenue Trends: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Regeneron Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Veracyte, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: MorphoSys AG vs Celldex Therapeutics, Inc.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.